Study types
- article 7
- other 1
- preprint 1
Condition tags
- adenomyosis 6
- dysmenorrhea 3
- mesh:D004715 3
- endometriosis 3
- mesh:D004412 3
- mesh:D017699 1
Top journals
Frequent coauthors
- Ming Yuan 8
- Hao Sun 8
- Xinyu Wang 8
- Xue Jiao 8
- Qianhui Ren 8
- Guoyun Wang 7
- Shumin Yan 6
- Dong Li 2
- Xiangyi Dong 2
- Jun Dai 2
article
2024
Background and Aims The association of the triglyceride-glucose (TyG) index, a promising novel biomarker for insulin resistance, with the risk of endometriosis has not been investigated to date. This nationwide study aimed to explore the as…
article
2024
OBJECTIVE: We carried out this study to explore the possibility of initiating goserelin therapy during the non-menstrual period in patients diagnosed with adenomyosis. METHODS: 115 premenopausal adenomyosis patients were enrolled and divide…
article
2024
BACKGROUND: Adenomyosis is a commonly observed benign gynecological disease that affects the quality of life and social psychology of women of childbearing age. However, because of the unknown etiology and incidence of adenomyosis, its path…
article
2023
BACKGROUND: To determine whether there is a correlation between stiffness measured by strain elastography and the severity of dysmenorrhea and to determine the value of elastography in evaluating severe dysmenorrhea in patients with adenomy…
article
2023
The management of endometriosis has been complicated by the COVID-19 pandemic. We aimed to introduce the establishment and application of a new follow-up method during the COVID-19 pandemic—the electronic follow-up (e-follow-up) platform fo…
article
2023
preprint
2023
other
2022
The absence of clinically objective methods to evaluate adenomyosis-associated pain and the poor understanding of its pathophysiology lead to treatment limitations. We conducted a resting-state functional magnetic resonance imaging study wi…
article
2022
OBJECTIVE: This prospective cohort study aimed to compare the clinical efficacy and safety of goserelin 10.8 mg administered trimonthly with goserelin 3.6 mg administered monthly in premenopausal females with symptomatic adenomyosis. METHOD…